Nevertheless, how treatment with anti-PD-L1 mAbs affects the composition and function of different lung tumor-infiltrating myeloid subsets in an orthotopic NSCLC model has not been addressed so far. This evidence concerns the gene CD274 and non-small cell lung carcinoma.